Martin Fan

Stock Analyst at Wedbush

(4.81)

# 91

Out of 5,124 analysts

16

Total ratings

86.67%

Success rate

73.93%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Martin Fan

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ZBIO Zenas BioPharma	Reiterates: Outperform	$45	$36.31	+23.93%	3	Dec 22, 2025
	VOR Vor Biopharma	Assumes: Neutral	$9	$13.08	-31.19%	1	Nov 25, 2025
	IMA ImageneBio	Assumes: Underperform	$2	$6.90	-71.01%	1	Nov 25, 2025
	ANAB AnaptysBio	Reiterates: Outperform	$50	$48.48	+3.14%	4	Nov 24, 2025
	SANA Sana Biotechnology	Maintains: Outperform	$5 → $6	$4.07	+47.42%	2	Nov 7, 2025
	ARTV Artiva Biotherapeutics	Maintains: Outperform	$18 → $23	$4.29	+436.13%	2	Oct 17, 2025
	RNAC Cartesian Therapeutics	Initiates: Outperform	$38	$7.21	+427.05%	1	Jul 9, 2025
	ACRS Aclaris Therapeutics	Initiates: Outperform	$8	$3.01	+165.78%	1	May 28, 2025
	ORKA Oruka Therapeutics	Reiterates: Outperform	$40	$30.31	+31.97%	1	May 15, 2025

Zenas BioPharma

Dec 22, 2025

Reiterates: Outperform

Price Target: $45

Current: $36.31

Upside: +23.93%

Vor Biopharma

Nov 25, 2025

Assumes: Neutral

Price Target: $9

Current: $13.08

Upside: -31.19%

ImageneBio

Nov 25, 2025

Assumes: Underperform

Price Target: $2

Current: $6.90

Upside: -71.01%

AnaptysBio

Nov 24, 2025

Reiterates: Outperform

Price Target: $50

Current: $48.48

Upside: +3.14%

Sana Biotechnology

Nov 7, 2025

Maintains: Outperform

Price Target: $5 → $6

Current: $4.07

Upside: +47.42%

Artiva Biotherapeutics

Oct 17, 2025

Maintains: Outperform

Price Target: $18 → $23

Current: $4.29

Upside: +436.13%

Cartesian Therapeutics

Jul 9, 2025

Initiates: Outperform

Price Target: $38

Current: $7.21

Upside: +427.05%

Aclaris Therapeutics

May 28, 2025

Initiates: Outperform

Price Target: $8

Current: $3.01

Upside: +165.78%

Oruka Therapeutics

May 15, 2025

Reiterates: Outperform

Price Target: $40

Current: $30.31

Upside: +31.97%